CLBT vs NICE: fair value comparison
Cellebrite DI Ltd. and NICE Ltd. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Technology, NICE currently sits closer to the top of our ranking by discount to fair value.
| CLBT | NICE | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $11.03 | $112.17 |
| 12-month range | $10.44–$19.28 | $83.15–$136.90 |
| Rank by discount to fair value | #26 of 181 Technology | #21 of 181 Technology |
| Quality grade | A | A |
| Momentum grade | — | A |
| Leverage | Low | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Uptrend |
| DCF cross-check | Overvalued | Undervalued |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: CLBT fair value analysis · NICE fair value analysis